NOXO
NOXOPHARM OPT JUN23 [NOXO]
About NOXO
Noxopharm is an Australian publicly listed (NOX) clinical stage drug development company that has a primary focus on the development of Veyonda as an adjuvant therapy in chemotherapy and radiotherapy in the treatment of late-stage cancers.
Buy Australian shares starting with NOXO. Invest today with a CHESS-sponsored broker!
Market Capitalisation
$29M
Price-earnings ratio
-0.09
Dividend yield
0.00%
High today
$0.01
Low today
$0.01
Open price
$0.01
52-week high
$0.16
52-week low
$0.01
Announcements
NOXO FAQs
How much is one share of NOXOPHARM OPT JUN23 [NOXO]?
One share of NOXOPHARM OPT JUN23 [NOXO] is valued at $0.01.
What is the ticker symbol for NOXOPHARM OPT JUN23 [NOXO]?
The ticker symbol for NOXOPHARM OPT JUN23 [NOXO] is NOXO.
How do I buy NOXO shares in Australia?
To buy NOXO stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in NOXO
What is the 52-week high for NOXOPHARM OPT JUN23 [NOXO] stock?
The NOXOPHARM OPT JUN23 [NOXO] 52-week high stock price is $0.16.
What is the 52-week low for NOXOPHARM OPT JUN23 [NOXO] stock?
The NOXOPHARM OPT JUN23 [NOXO] 52-week low stock price is $0.01.
What is the market capitalisation of NOXOPHARM OPT JUN23 [NOXO] NOXO?
As of 21/03/2023 NOXOPHARM OPT JUN23 [NOXO] has a market cap of $29M.
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.